Daily Schedule - Saturday - September 20

Educational Session: Molecular Pathology and Classification of Hematological Malignancies
Session Chairperson: Clara D. Bloomfield, The Ohio State University, Columbus, Ohio
4:00 p.m.-5:30 p.m.

Clinical significance of molecular findings in acute myeloid leukemia
Clara D. Bloomfield

Principles of lymphoma classification
Laurence DeLeval, University Hospital of Lausanne, Lausanne, Switzerland

Genetic landscape of myeloma and its clinical significance
Faith Davies, Institute of Cancer Research and Royal Marsden Hospital, London, U.K.

Free Time / Dinner on Own
5:30 p.m.-6:30 p.m.

Welcome and Opening Keynote Session
Session Chairperson: Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston, Mass.
6:30 p.m.-9:00 p.m.

Welcome Remarks
Margaret Foti, CEO, American Association for Cancer Research
Kenneth C. Anderson, Conference Chairperson

Keynote Talks

The future of epigenetics: Cancer therapy through cellular rehabilitation rather than execution
Craig B. Thompson, Memorial Sloan Kettering Cancer Center, New York, N.Y.

The accomplishments and impact of Janet D. Rowley
Michelle M. Le Beau, University of Chicago Comprehensive Cancer Center, Chicago, Ill.

Keynote Memorial Lecture, dedicated to Janet D. Rowley
Novel function of microRNAs

Carlo M. Croce, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Opening Reception

9:00 p.m.-10:30 p.m.